Do maternally administered neuromuscular blocking agents interfere with fetal neuromuscular transmission?
D000470:Alkaloids / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D002335:Carnivora; D002415:Cats; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005703:Gallamine Triethiodide / Q000008:administration & dosage / Q000494:pharmacology; D007211:Indoles / Q000008:administration & dosage / Q000494:pharmacology; D008431:Maternal-Fetal Exchange; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000187:drug effects*; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D010197:Pancuronium / Q000008:administration & dosage / Q000494:pharmacology; D011247:Pregnancy; D013390:Succinylcholine / Q000008:administration & dosage / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects*; D013997:Time Factors; D014403:Tubocurarine / Q000008:administration & dosage / Q000494:pharmacology
D000470:Alkaloids; D007211:Indoles; D009467:Neuromuscular Depolarizing Agents; D013390:Succinylcholine; D010197:Pancuronium; D005703:Gallamine Triethiodide; D014403:Tubocurarine